ClinicalTrials.Veeva

Menu

Prospective Randomized Study on Clinical Effectiveness of Carvo-Tricuspid Isthmus Block in Patients With Paroxysmal Atrial Fibrillation

Yonsei University logo

Yonsei University

Status

Completed

Conditions

Atrial Fibrillation

Treatments

Procedure: PVI
Procedure: PVI, CTI block

Study type

Interventional

Funder types

Other

Identifiers

NCT02019407
4-2013-0639

Details and patient eligibility

About

Prospective Randomized Study on Clinical Effectiveness of Carvo-Tricuspid Isthmus (CTI) Block in Patients with Paroxysmal Atrial Fibrillation (PAF) will be performed. Study will be composed with two arms including 4 pulmonary vein isolation and pulmonary vein isolation with CTI block. After that all patients will be followed up by HRS(Heart Rhythm Society) 2010 expert consensus guideline.

Enrollment

128 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with documented AF
  • Drug refractory AF
  • Non-valvular AF
  • No structural cardiac disease
  • No intracardiac thrombi in cardiac CT and TEE

Exclusion criteria

  • permanent AF refractory to electrical cardioversion
  • LA size >55 mm as measured by echocardiography
  • AF with valvular disease
  • associated structural heart disease other than left ventricular hypertrophy
  • prior AF ablation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

128 participants in 2 patient groups, including a placebo group

CTI group
Experimental group
Description:
CTI(Cavo-Tricuspid Isthmus)
Treatment:
Procedure: PVI, CTI block
Non CTI group
Placebo Comparator group
Description:
Non CTI (Cavo-Tricuspid Isthmus)
Treatment:
Procedure: PVI

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems